Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
about
Modeling Influenza Virus Infection: A Roadmap for Influenza ResearchImmune Responses to Influenza Virus and Its Correlation to Age and Inherited FactorsA review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges aheadNeuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadInnate immune induction and influenza protection elicited by a response-selective agonist of human C5aCAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferretsImmunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in miceConserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentModel-based simulation and prediction of an antiviral strategy against influenza A infection.Does homologous reinfection drive multiple-wave influenza outbreaks? Accounting for immunodynamics in epidemiological models.Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutininInfection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in micePostinfluenza bacterial pneumonia: host defenses gone awry.Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.Passive immune neutralization strategies for prevention and control of influenza A infections.Prior infection of pigs with a recent human H3N2 influenza virus confers minimal cross-protection against a European swine H3N2 virusDetrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumoniaProphylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins.Partial depletion of natural CD4⁺CD25⁺ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection.Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoproteinA large-scale immuno-epidemiological simulation of influenza A epidemicsPathological and ultrastructural analysis of surgical lung biopsies in patients with swine-origin influenza type A/H1N1 and acute respiratory failure.The airway epithelium: soldier in the fight against respiratory virusesRobust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coliEvaluation of influenza-specific humoral response by microbead array analysisRecombinant nipah virus vaccines protect pigs against challengeCollectivism/individualism and its relationship to behavioral and physiological immunity.Protective B cell responses to flu--no fluke!The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study.A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in agingIdentification and Analysis of Natural Killer Cells in Murine Nasal PassagesDietary lactosucrose suppresses influenza A (H1N1) virus infection in mice.Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance.Roles of Mucosal Immunity against Mycobacterium tuberculosis InfectionInfluenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients
P2860
Q26782421-BC53D8AF-7F8B-4561-BD8F-E932B45639A0Q28075495-8873F7AD-0550-47B8-99C8-49D2460089FCQ28382972-FDE2A8CB-9810-4338-AB50-3DFD5DDFC861Q28471814-C624C93F-543E-4E60-B555-509A5B8E1FC0Q28727437-92611B64-A25B-4023-B033-9B03392DBF6FQ28741710-DB767932-ADD7-4CEF-B5C9-852516F2FE0DQ28743887-0E9768C8-E5E2-42DB-BCE6-669A878885DEQ30226873-8A44A877-200F-466E-9077-72CA114F1530Q30352246-3797D114-1312-4823-BC01-FA5B940B8D07Q30355921-C5CB0751-1738-445C-A2DE-E0F7140212DBQ30361736-5C9AE880-8346-47D2-8DCA-08D1901EE02CQ30376369-F7FE953D-8EBD-41E6-80F6-22F98FC5105CQ30377228-3E7AFEC0-A588-450A-BD9B-A01D7970B33DQ30389582-55EC838E-5CBA-4D49-8798-27FBD3F81D1FQ30391974-10BD0D0B-EE2C-40C9-ABEC-42E4E4A858F2Q30392817-F62CF863-6418-40D0-9566-A91635FFB255Q30403077-B3BBB217-8E13-4969-86C8-D58995924F11Q30404699-338210BE-9C18-49D5-964D-A15DE8EF5389Q30413158-53EFE50B-5482-4756-A70C-B16D861921C7Q30428962-95B5A8BF-B624-43A3-BE8F-EF00E058AF52Q33247462-5C180FAB-1A11-4CD2-8E9E-72C5A4D9CDC5Q33676552-47E7CAC7-E54D-45AA-9D8C-AC8C17855DD3Q33905228-4884C821-BD83-4D6B-AA34-F1C03D6CD4FDQ34085796-A88321A9-9FA3-4357-AA8A-26343AB4568CQ34261503-37466C6F-ABD2-421E-A1EE-34B0A274FE11Q34326011-850B13EE-39B1-4314-BBE4-453C125D1FFBQ34486922-2AFD598A-2052-4FDF-B001-077989D77C6FQ34491598-451EFC93-0C04-4A54-A3EC-91EE203804A3Q34533990-F7377F22-EA46-4B2E-88D1-69B88658CFC1Q34789793-A714D5C4-C62E-4E0B-B8E3-D090D09622E3Q35023946-B34EAEF5-1FBF-450C-99B3-885D7AA6E6A2Q35136165-77419726-220C-41B8-8925-EBF3A00277D9Q35158499-E049F166-3413-4CA3-8E3B-6ADABD4783AAQ35589073-7C421558-506E-4994-BA2D-28C81C923ECFQ35661214-B5EA7744-AF4E-4F7A-93DD-119A0CE3BE0CQ35843608-55EECC37-77B2-43EC-8086-D29204BDFD89Q36302156-1946D4B6-6194-4921-8F95-BA40CF9252D8Q36315437-19B5C96F-347D-4BAE-ABB7-6AF4FAE0B1CAQ36417953-A0950B2C-97D9-4F99-9A63-4917F3BF934BQ37071008-D6055884-1966-4317-B41C-F8FB25B0EDC3
P2860
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
@ast
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
@en
type
label
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
@ast
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
@en
prefLabel
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
@ast
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
@en
P1476
Defense mechanisms against influenza virus infection in the respiratory tract mucosa
@en
P2093
Shin-ichi Tamura
Takeshi Kurata
P304
P577
2004-12-01T00:00:00Z